News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds - MedCity News
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly and it’s now preparing for Phase 3 testing. But an oral obesity drug in Amgen’s pipeline will not advance beyond Phase 1.
Q1 Was Pretty Good For Hospital Finance — But It’s Unclear If It Will Stay That Way - MedCity News
Hospitals’ operating margins and patient volumes dropped slightly in March. While hospitals were doing relatively well financially during the first quarter of the year, this new data could suggest more financial challenges ahead for hospitals. But right now, it’s unclear whether the recent declines in hospitals’ margins and volumes will be short- or long-term.
Navigating the Transition to Value-Based Care: Addressing Fears and Embracing Risk in ACO REACH - MedCity News
Offering blended options, individual risk pools, and net neutral capitation payments providers can embark on their journey toward value-based care at a pace aligned with their tolerance and readiness.
Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition - MedCity News
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big pharma M&A moves in the red-hot radiopharmaceuticals space.
Kaiser Permanente Is Deploying Innovaccer’s Value-Based Care AI Across Washington - MedCity News
Kaiser Permanente is deploying Innovaccer’s healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and potentially expanding to new markets in the future.
Generational Intel: Helping Patients Identify Where to Seek Care - MedCity News
Communication with patients should be a top area of focus as urgent cares look to develop their marketing strategies, tailored to each generation they are trying to reach, with an eye toward relieving unnecessary demand on emergency departments.
Healthcare Is a Frontier Not Even Walmart Could Conquer — And It’s Not Looking Great For Others Either - MedCity News
Walmart’s decision to shutter its healthcare division reflects just how difficult it is to achieve profitability in the primary care and telehealth markets. Experts think retailers simply aren’t prepared to handle the bevy of challenges that come along with delivering healthcare — but could this news also be a sign of the system being broken?
An Ohio Pharmacy Was Fined $250K. It Represents Everything Wrong With the Prescription Drug Industry. - MedCity News
We must realign the financial incentives and democratize access through data sharing. Pharma needs to lead the charge, but employers and pharmacies must also be agents of change. Here’s how we can do it.
Pepper Bio’s ‘Google Maps for Drug Discovery’ Finds Way to Potential New Liver Cancer Drug - MedCity News
Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same drug class. EQRx previously held rights to the drug, but returned them after the company was acquired last year.
The Evolution of eConsent Management for Mental Health, Substance Use Disorders Data - MedCity News
In a discussion led by Aneesh Chopra, president of CareJourney, health tech organizations and providers discussed the protected health information (PHI) consent gaps and complex workflows impeding interoperability, and how companies such as Docusign are addressing them.
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Adaeze Enekwechi, CEO of Cayaba Care - MedCity News
In this month’s episode, Senior Reporter Katie Adams explored some executive hires and exits that recently occurred in the healthcare world, as well as layoffs affecting the industry. She also interviewed Adaeze Enekwechi, who became CEO of Cayaba Care this month.
J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer - MedCity News
Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies.
Four Innovative Canadian Medtech Startups to Watch at MedCity INVEST - MedCity News
The group of four healthcare startups spans women's health, orthopedics, remote patient monitoring for Parkinson's disease, AI, and 3D printing. David Kereiakes, Managing Partner, Windham Venture Partners will moderate the session.
Abbott Earns FDA Approval For Dissolving Stent That Unclogs Arteries Below The Knee - MedCity News
Abbott earned FDA approval for its dissolving stent designed to unclog arteries below the knee. This marks the first time the FDA has approved a stent or drug-coated balloon to help arteries stay open below the knee.
Ono Pharma’s Plan to Become a Global Player Picks Up a New Piece With $2.4B Deciphera Acquisition - MedCity News
Ono Pharmaceutical’s acquisition of Deciphera Pharmaceuticals adds to a cancer drug pipeline that already spans multiple modalities. Deciphera develops drugs that target the on-off switch of enzymes that drive cancer cell growth.
What’s Keeping Healthcare CIOs Up at Night: How Health Systems Automate Routine Phone Calls to Improve Workforce Effectiveness and Reduce Agent Burnout - MedCity News
With hospitals struggling to retain staff and value-based care shrinking healthcare revenues, health systems must look to technology resources to become more efficient, without losing sight of patient care or staff support.
Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency - MedCity News
The FDA approved X4 Pharmaceuticals drug Xolremdi for treating WHIM syndrome. The molecule, which addresses the underlying cause of this rare immunodeficiency, was licensed from Sanofi’s Genzyme subsidiary.
Experts Aren’t Surprised About Optum Closing Its Virtual Care Business - MedCity News
Optum is shutting down its virtual care unit after a three-year run. Industry experts agree that the closure reflects broader trends in the telehealth market, in which saturation and differentiation challenges are leading some providers to struggle.
An Oveview of the Nation's Largest SEED Fund - MedCity News
Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding comes in tranches, from $300,000 - $4 million, based upon the stage of development and likelihood of the end product “moving the needle” in healthcare.
Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction - MedCity News
Labcorp’s $239 million offer was selected as the winning bid for the assets of genetic testing company Invitae, which filed for bankruptcy protection earlier this year. The acquisition deal, Labcorp's second in the past month, will enable it to expand in oncology and rare diseases.